San Antonio Breast Conference
You may already be aware that the annual San Antonio Breast Cancer meetings are next week (December 6-10). This is the largest yearly conference about breast cancer, and there are always many news reports and, sometimes, some exciting research. Do remember to read anything in the press with your "skeptical glasses" on. Journalists are in the business of selling papers and go for the big headline. Too many times, I have read media stories that seem to promise a cure--and we all know where we, sadly, stand on that one.
Here is an article from MedScape about what to look for next week. I give you the introduction and then a link:
What's Hot at the 2011 San Antonio Breast Cancer Symposium
November 28, 2011 - Results from a number of high-profile clinical trials of bisphosphonates in breast cancer will be among the headlining news from the 34th Annual San Antonio Breast Cancer Symposium (SABCS), being held December 6 to 10 in Texas.
Vying for attention at the meeting will be the Institute of Medicine's report on environmental factors and breast cancer as well as new results from major clinical trials in advanced breast cancer. Additionally, there will be a report on the first-ever genomic profiling study of ductal carcinoma in situ (DCIS), an analysis of the overdiagnosis of breast cancer from mammography screening, and the results from an international study of
axillary lymph node dissection in patients with clinically node-negative breast cancer and micrometastases in the sentinel node.
Overall, the 2011 meeting looks especially exciting, said Peter Ravdin, MD, PhD, a co-director of the symposium. "We have a lot of outstanding presentations this year, even more so than usual," he told Medscape Medical News. Dr. Ravdin
is director of the Comprehensive Breast Health Clinic at the Cancer Therapy & Research Center, University of Texas Health Science Center at San Antonio.
There will be presentations of new data from 4 separate clinical trials of bisphosphonates in patients with breast cancer.